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for France in 2001 indicated that while 88% of
family members received antibiotic prophylaxis,
only 58% of colleagues, friends or other people
in close contact with primary cases were given
antibiotics [6]. The outbreak reported in the
present study highlights the importance of very
early prophylaxis to prevent secondary cases
among a family or close contacts. In the present
study, at least one patient (who died) was in
close contact with the brother of another
patient.
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ABSTRACT
Investigation of two cases of invasive meningo-
coccal disease within a single family revealed the
presence of isolates of Neisseria meningitidis phe-
notype C:2b:P1.2,P1.5 belonging to sequence type
(ST) 66. The ST66 clone is a single-locus variant of
the widely distributed ST8 complex, which has
been observed previously in Spain, Belgium,
Australia and New Zealand. This hypervariable
meningococcal lineage has been responsible for
local epidemics worldwide. This is the first report
of ST66 meningococcal isolates of this phenotype
from Poland.
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Neisseria meningitidis is responsible for various
kinds of infections, of which septicaemia and
meningitis are the most severe, but the organism
can also be carried in the nasopharynx of healthy
individuals. Meningococcal infections usually
occur sporadically, but local or large-scale out-
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breaks have been observed [1–5]. The present
study investigated the epidemiological situation
within a family in which two cases of invasive
meningococcal disease were diagnosed.
The first patient (a boy aged 5.5 years) was
admitted to hospital in Cracow with classical
signs of meningeal infection. After lumbar punc-
ture, therapy with cefotaxime and corticosteroids
was initiated. The cerebrospinal fluid (CSF) was
purulent with significant pleocytosis, a protein
level of 2.6 g ⁄L, and a glucose level of
0.5 mmol ⁄L. N. meningitidis was isolated from
the CSF. The boy was discharged after hospital-
isation for 17 days, with slight ataxia and loss of
hearing in the left ear (40 dB).
One day after the first case was admitted, the
patient’s 8-year-old brother was also admitted to
the hospital, with high fever (39.6C), vomiting,
purpura fulminans and meningeal signs. Ampi-
cillin, amikacin, corticosteroids, globulins and
infusion fluids were administered immediately.
A lumbar puncture was performed after three
doses of antibiotics. The CSF was purulent with
significant pleocytosis, a protein level of 5.3 g ⁄L,
and a glucose level of 2.62 mmol ⁄L. No microor-
ganism was cultured from the CSF and blood
samples, but the Wellcogen polyvalent latex test
(Murex Biotech, Dartford, UK) detected antigens
for N. meningitidis serogroups A, C, Y and W135 in
the CSF. The patient was hospitalised for 16 days
and discharged without any complications.
One month after the index case, nasopharyn-
geal swabs were taken from the two patients, a
brother aged 4.5 years and the parents. Men-
ingococci were isolated from the first patient and
the parents. Chemoprophylaxis was not admin-
istered to any member of the family. Four
meningococcal isolates (from the CSF of the first
patient, and from the nasopharyngeal swabs
taken from the first patient and his parents)
were serotyped by standard methods [6] at the
National Reference Centre for Bacterial Menin-
gitis (Warsaw, Poland). MICs of penicillin,
ceftriaxone, cefotaxime, rifampicin and ciprofl-
oxacin were determined by Etest (AB Biodisk,
Solna, Sweden), with results interpreted accord-
ing to the National Committee for Clinical
Laboratory Standards criteria for Streptococcus
pneumoniae [7]. Genetic relatedness of the isolates
was studied by randomly amplified polymorphic
DNA analysis with three primers (AP-1254,
AP-1281 and AP-1283 [8,9]), pulsed-field gel
electrophoresis (PFGE) with BglII, NotI and BcuI
restriction endonucleases (MBI Fermentas,
Vilnius, Lithuania) [2], and multilocus sequence
typing (MLST) (http://www.mlst.net) [10,11].
All four meningococcal isolates were suscept-
ible to all the antimicrobial agents tested, had the
phenotype C:2b:P1.2,P1.5, and were indistin-
guishable by randomly amplified polymorphic
DNA analysis, PFGE with NotI and BcuI, and
MLST analysis (all belonged to sequence type (ST)
66 with the allelic profile 2-3-7-6-8-5-2). PFGE
analysis with BglII differentiated the first patient’s
CSF isolate from the three isolates derived from
nasopharyngeal swabs (Fig. 1).
An interesting feature was the continued car-
riage of meningococci in the first patient, ob-
served 1 month after successful treatment of the
infection with cefotaxime. Third-generation
cephalosporins are known to be effective in the
treatment of invasive meningococcal disease and
in eradication of meningococcal carriage [1].
Considering this, it is possible that the first patient
reacquired the strain from his parents after
recovery, although meningococcal recolonisation
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Fig. 1. Pulsed-field gel electrophoresis patterns of men-
ingococcal DNA digested with BglII (lanes 1–4) and BcuI
(lanes 5–8). Lanes 1 and 5: isolate from CSF (patient 1).
Lanes 4 and 6: isolate from nasopharynx (patient 1). Lanes
2 and 7: isolate from nasopharynx (father). Lanes 3 and 8:
isolate from nasopharynx (mother). Lanes S: molecular size
marker (lambda DNA Ladder; New England Biolabs,
Beverly, MA, USA).
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The typing data indicated that the four isolates
were closely related and originated from a single
meningococcal strain. However, PFGE analysis
with BglII showed a slight difference between
meningitis-related and carriage isolates, perhaps
corresponding to a single genetic event, which
probably illustrates ongoing diversification of the
original strain. A single point mutation in men-
ingococcal DNA, leading to a change in the
capsule phase, may be responsible for the switch
of the organism from the carrier to the invasive
state [12]. Therefore, it cannot be excluded that
the observed change in PFGE patterns was in
some way connected with the invasive potential
of one of the variants.
The observed difference in PFGE patterns
confirmed earlier observations that this tech-
nique is more suitable for tracking the micro-
evolution of meningococcal strains than the
relatively less-discriminatory MLST [3,4]. Never-
theless, MLST enables fast and unambiguous
identification of pathogenic strains via the MLST
internet data-base (http://www.mlst.net). The
meningococcal isolates in this study were of
the ST66 type, which has been observed previ-
ously in Spain, Belgium, Australia and New
Zealand (http://www.mlst.net) [13]. ST66 is a
single-locus variant of the ST8 clone, and both
are members of the widely distributed ST8
complex. ST8 isolates belonging to serogroups
B and C were recovered frequently in Spain in
the 1990s; single isolates have also been reported
in other countries, including the Czech Republic,
The Netherlands, the UK, Greece, France and
South Africa (http://www.mlst.net). The ST8
clone and related isolates, including ST66, have
been assigned by multilocus enzyme electro-
phoresis to N. meningitidis cluster A4 [11]. This
hyper-virulent, expanding meningococcal lin-
eage has been responsible for local epidemics
in Europe, North and South America, Australia
and South Africa, especially in children [3]. The
ST66 meningococcal isolates analysed in this
study belonged to phenotype C:2b:P1.2,P1.5, and
this is the first description of such isolates from
Poland.
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